Early diagnosis can save babies' lives: A guide to severe combined immunodeficiency disease (SCID)

December 18, 2017

A new review provides guidance on a deadly, but rare, disease that is potentially curable if identified early. Severe combined immunodeficiency disease (SCID), known as the "bubble boy disease" in the 1970s, is treatable with a stem cell transplant, gene therapy and other treatments if identified at birth or soon after.

The review, published in CMAJ (Canadian Medical Association Journal), is aimed at pediatricians, family physicians and other doctors who may treat newborns, including those who appear healthy at birth but begin to get severe, repeated infections requiring emergency department visits.

The death rate for severe combined immunodeficiency disease is at least 30%, with infection causing 60% of deaths in infants.

Ontario was the first jurisdiction in Canada to offer screening for severe combined immunodeficiency disease in 2013 as part of the heel prick test performed soon after birth. Screening has been expanded to the Maritime provinces and will be implemented in several other provinces.

"This review informs physicians who may treat newborns in their practice (e.g., family physicians, obstetricians, pediatricians) on how to approach patients and counsel families who are faced with an abnormal screen," writes Dr. Stuart Turvey, a professor with the UBC Department of Pediatrics and an investigator, BC Children's Hospital, Vancouver, BC, with coauthors.

The review includes features to watch for in newborns with repeated illnesses, information on screening and diagnosis, and treatments for the disease, as well as the approach and support for parents of babies who may receive a positive screen, including false positives.

"The opportunity to identify severe combined immunodeficiency early in life has transformed outcomes for this otherwise fatal condition. Introducing this assay into newborn screening programs throughout Canada has the potential to save lives and prevent suffering of patients and families affected by this condition," the authors conclude.

The review was created by a pan-Canadian group of physicians from BC Children's Hospital, University of British Columbia, Vancouver, BC; University of Montreal and CHU Sainte-Justine, Montréal, Quebec; IWK Health Centre and Dalhousie University, Halifax, Nova Scotia; and The Hospital for Sick Children and the University of Toronto, Toronto, Ontario.
-end-
"Newborn screening for severe combined immunodeficiency: a primer for clinicians" is published December 18, 2017.

Canadian Medical Association Journal

Related Disease Articles from Brightsurf:

CLCN6 identified as disease gene for a severe form of lysosomal neurodegenerative disease
A mutation in the CLCN6 gene is associated with a novel, particularly severe neurodegenerative disorder.

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

Potential link for Alzheimer's disease and common brain disease that mimics its symptoms
A new study by investigators from Brigham and Women's Hospital uncovered a group of closely related genes that may capture molecular links between Alzheimer's disease and Limbic-predominant Age-related TDP-43 Encephalopathy, or LATE, a recently recognized common brain disorder that can mimic Alzheimer's symptoms.

Antioxidant agent may prevent chronic kidney disease and Parkinson's disease
Researchers from Osaka University developed a novel dietary silicon-based antioxidant agent with renoprotective and neuroprotective effects.

Tools used to study human disease reveal coral disease risk factors
In a study published in Scientific Reports, a team of international researchers led by University of Hawai'i (UH) at Mānoa postdoctoral fellow Jamie Caldwell used a statistical technique typically employed in human epidemiology to determine the ecological risk factors affecting the prevalence of two coral diseases--growth anomalies, abnormalities like coral tumors, and white syndromes, infectious diseases similar to flesh eating bacteria.

Disease-aggravating mutation found in a mouse model of neonatal mitochondrial disease
The new mitochondrial DNA (mtDNA) variant drastically speeds up the disease progression in a mouse model of GRACILE syndrome.

Human longevity largest study of its kind shows early detection of disease & disease risks
Human Longevity, Inc. (HLI) announced the publication of a ground-breaking study in the journal Proceedings of the National Academy of Sciences (PNAS).

30-year study identifies need of disease-modifying therapies for maple syrup urine disease
A new study analyzes 30 years of patient data and details the clinical course of 184 individuals with genetically diverse forms of Maple Syrup Urine Disease (MSUD), which is among the most volatile and dangerous inherited metabolic disorders.

Long-dormant disease becomes most dominant foliar disease in New York onion crops
Until recently, Stemphylium leaf blight has been considered a minor foliar disease as it has not done much damage in New York since the early 1990s.

Read More: Disease News and Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.